Repare Therapeutics Announces March 2021 Virtual Investor Conference ParticipationBusiness Wire • 02/23/21
Repare Therapeutics Insiders Establish Automatic Securities Disposition PlansBusiness Wire • 12/31/20
Repare Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceBusiness Wire • 11/23/20
Repare Therapeutics Reports Third Quarter 2020 Financial Results and Operational HighlightsBusiness Wire • 11/11/20
Why Earnings Season Could Be Great for Repare Therapeutics (RPTX)Zacks Investment Research • 11/11/20
Repare Therapeutics to Participate at Morgan Stanley Annual Global Healthcare ConferenceBusiness Wire • 09/09/20
Repare Therapeutics Reports Second Quarter 2020 Financial Results and Operational HighlightsBusiness Wire • 08/13/20
Repare Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of RP-3500Business Wire • 07/29/20
Repare Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesBusiness Wire • 06/23/20